Form 4/A for CDNA CareDx, Inc.
Accepted 2024-04-09 00:00:00 ET · period of report 2024-02-01 · accession 0001217234-24-000035 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2024-04-09 | 2024-02-01 | CDNA | Johnson Alexander L | See Remarks | A - Grant | $0.00 | +174.5K | 345.5K | +102% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-01 | A | A | 174,520 | $0.00 | 345,533 | D | — | — | (F1) This amendment is being filed to report the grant of restricted stock units which was inadvertently omitted from the original Form 4 filed on February 5, 2024. This resulted in an additional 174,520 shares deemed beneficially owned by the Reporting Person which were inadvertently omitted from the original Form 4 and were also omitted from one Form 4 filed by the Reporting Person on February 6, 2024, which Form 4 should therefore have reflected a total of 344,413 shares deemed beneficially owned in Table I, Column 5. (F2) The reported securities are represented by restricted stock units, 1/12th of which shall vest on May 1, 2024 and 1/12th of which shall vest on each date that is three months thereafter. |